Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-047062
Filing Date
2015-08-07
Accepted
2015-08-07 06:02:41
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v415490_10q.htm 10-Q 573765
2 EXHIBIT 31.1 v415490_ex31-1.htm EX-31.1 7485
3 EXHIBIT 31.2 v415490_ex31-2.htm EX-31.2 7444
4 EXHIBIT 32.1 v415490_ex32-1.htm EX-32.1 4080
  Complete submission text file 0001144204-15-047062.txt   5333754

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT icpt-20150630.xml EX-101.INS 1745783
6 XBRL TAXONOMY EXTENSION SCHEMA icpt-20150630.xsd EX-101.SCH 32881
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE icpt-20150630_cal.xml EX-101.CAL 30105
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE icpt-20150630_def.xml EX-101.DEF 87261
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20150630_lab.xml EX-101.LAB 251447
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20150630_pre.xml EX-101.PRE 205155
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 151034858
SIC: 2834 Pharmaceutical Preparations